I-Tech: A Regulatory Coin-Flip Masks a Quiet Aquaculture Pivot

Q3 growth held, but the EU vote and a titanium-surface license are the real story.

ITECH.ST · Earnings Call · 2026-10-16

A record quarter gives way to lumpy orders

I-Tech's third quarter is best read as a growth company hitting an air pocket, not a growth company stalling. Net sales rose 19% to SEK 48.8 million, organic growth was 18%, gross margin held at 60% versus 57%, EBITDA rose 16% to SEK 15.1 million and EBIT 20% to SEK 13.3 million, with SEK 177 million of cash. The sequential decline from Q2's record is the headline, but management attributes it to order timing: “if one order ends up on one or the other side of a quarter, it can actually have a big impact” — Markus Jönsson, CEO · 2026-10-16. That is credible for a business with a handful of coating customers placing large orders; it is also the same explanation that keeps recurring. The company's own keyword set is dominated by biggest customer and second-biggest-customer recovery, not by a new demand driver. The customer concentration cuts both ways. Management says the second-largest customer recovered faster than expected and that momentum persisted through Q1, Q2 and Q3, with a substantial contribution to Q3 growth. Asked if that was restocking, the CEO argued Selektope is too expensive to sit on and paint manufacturing is just-in-time: “the stocking effect is quite minimal for our type of business” — Markus Jönsson, CEO · 2026-10-16. That is an important defense, but it does not remove the dependence. Korea was 46% of year-to-date sales, Japan 27%, China 21%, Singapore 3% and Europe 3%. Around 60% of Selektope sales go into newbuilds and 40% into the service market, with China the key service market to crack. The macro backdrop is unusually supportive. Charter rates are up 61% year on year, new ship ordering is up 33% versus full-year 2025, shipyard output is up 14% year to date, and China accounts for more than 60% of the dry docking market and nearly 60% of new vessels. I-Tech still penetrates only about 3,500 of 110,000 commercial vessels. The mini-boom in shipping matters because it pulls forward coating demand, but the timing lag is long: vessels ordered now are coated roughly three years out. So the macro is a 2027-2028 tailwind, not a Q4 rescue.

Europe: a binary risk that management insists is small

The more urgent issue is regulatory. Selektope's EU approval expires at the end of this year. A June Standing Committee meeting discussed a draft proposal for non-renewal; a written vote runs from October 7 to October 21. A decision could follow within one or two weeks, though there is no fixed deadline and the process needs political signature. If non-renewal passes, there is a 180-day transition period for existing stock, and restrictions would apply to paint placed on the EU market and to treated articles sold into the EU. Management's framing is deliberately narrow. Cecilia Ohlauson argued that paint containing Selektope cannot be sold within the EU and that a ship treated with it cannot be sold to an EU-based owner for EU use, but port calls and travel in EU waters continue. Her punchline:

Roughly 5% of the addressable market would be impacted, while 95% can continue as usual.
Cecilia Ohlauson, Regulatory Affairs or similar role · 2026-10-16

That is the central tension in the call. The member states vote is a binary headline risk for a small-cap specialty chemical, yet the company says the direct sales exposure is only about 5% of the addressable market and Europe was just 3% of year-to-date sales. The political path is not clean. The CEO noted that member states often vote with the European proposal, but that four no votes could create a blocking minority. “we remain very hopeful that there will be four European member states that actually do recognize the value” — Markus Jönsson, CEO · 2026-10-16. That is not a forecast; it is a hope. The market may price the headline as existential, while the company argues it is a manageable regional restriction. Both can be true: the direct revenue hit may be small, but the precedent and customer uncertainty are not. The company also flagged a petition with 30 organizations and an ongoing EOGRT study, with a CRO to be selected this year. Regulatory spending is now materially higher than before 2023.

Aquaculture is the genuinely new story

The strategic pivot is where this quarter becomes more than a regulatory holding pattern. I-Tech signed a worldwide exclusive license agreement with Spanish start-up Titanium Technology to commercialize an electrochemical titanium-surface technology in aquaculture. The technology applies a varying current to titanium to alter surface charge and pH, limiting microorganism settlement without a biocide. Pilot validation shown in the presentation included an LNG evaporation tank, a pipe with a clean titanium interior versus a fouled exterior, and grates. Management was careful: “what remains now is to prove the commercial validity of this technology for various aquaculture applications” — Markus Jönsson, CEO · 2026-10-16. This is early, but strategically coherent. Aquaculture qualification periods are shorter than the five-year dry-docking cycle in commercial shipping, and biofouling directly affects water flow, oxygen, pathogens, maintenance and animal yield. The license fee is recurring and performance-based, so it should scale only with success. I-Tech also has a bio-derived additive acquired before last quarter, with internal validation and prospect discussions; management suggested sales could come within a few years, while Titanium is too early to size. The company's ambition is to be more than a one-product Selektope story. That matters because the original Selektope patent has expired, leaving formulation and production patents, plus regulatory approvals, as the moat. The business development pipeline is now the swing factor for whether I-Tech becomes a platform or remains a regulatory-dependent single molecule.

What to watch

Near term, the EU vote outcome and the Q4 order pattern matter more than the long-run aquaculture optionality. The second-largest customer's recovery needs to prove sustainable rather than a restocking echo. raw material prices appear to have stabilized at elevated levels, and the 60% gross margin is management's target with a plus-or-minus two-point band, not a guarantee. The SEK 177 million cash pile is comfortable, but buybacks are off the table while I-Tech is on Nasdaq First North; management said it is awaiting a rule change and would consider both dividends and buybacks. This is a company-specific story, not a ride on a global theme. The global keyword tape is dominated by AI data centers, tariffs and power, none of which explains I-Tech. The real debate is whether a niche antifouling chemical can convert a shipping mini-boom and an aquaculture license into a broader product platform before the EU regulatory overhang distracts customers.